Nordion Inc (NDN.TO)

DON'T BUY
Has dropped through the $20 technical support level. Would look at it at $15.
BUY
Interesting component parts. Health care in the US is rallying.
PAST TOP PICK
(Was a top pick on Nov 5. Down 3.8%.) Still likes.
PAST TOP PICK
(Was a top pick on Oct 29. No change.) Still likes.
WAIT
Has concerns that the CFO has left on such short notice with no one ready to step in.
DON'T BUY
A defensive type of holding. Doesn't expect much upside.
BUY
Strong cash flow from their labs. Starting to fire on all cylinders now. Proteomics are looking better.
DON'T BUY
Fair market value is $27/28. Stock is in a trading range of $20/25.
WEAK BUY
Earnings have flattened out.
TOP PICK
(Was a top pick on Oct 10. Down 7.4%. ) Good production. Well focused management.
TOP PICK
Good portfolio of health related activities.
BUY
Their lab business could be sold at a premium. Keep a stop loss on it.
TOP PICK
(Was a top pick on July 2. Down 12.5%)
HOLD
Profitable. Well managed.
TOP PICK
Buy in low $20's and sell at $25.
Showing 76 to 90 of 229 entries